수의 분자진단 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global veterinary molecular diagnostics market size is expected to reach USD 5.34 Billion in 2034 from USD 2.06 Billion in 2025, growing at a CAGR of 11.14% during 2026-2034.The global veterinary molecular diagnostics market has grown as animal healthcare and disease detection technologies continue to advance. Veterinary molecular diagnostics involve the use of advanced laboratory techniques such as polymerase chain reaction and DNA analysis to detect infectious diseases in animals. These methods provide accurate and rapid identification of pathogens affecting livestock and companion animals.

Several factors are driving the growth of this market. The increasing demand for effective disease monitoring in livestock production has encouraged the use of advanced diagnostic tools. Farmers and veterinarians rely on molecular diagnostics to detect diseases early and prevent outbreaks. In addition, rising pet ownership has increased the need for advanced diagnostic services in veterinary clinics.

The future outlook for the veterinary molecular diagnostics market remains promising as animal health management becomes more sophisticated. Advances in genetic testing and portable diagnostic technologies may improve disease detection and monitoring capabilities. Increasing investments in veterinary healthcare and livestock management are expected to support market expansion. As the importance of animal health continues to grow, demand for molecular diagnostic technologies will likely increase.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Instruments
• Test Kits & Reagents
• Software & Services

By Animal Type

• Companion Animal
• Production Animals

By Technology

• PCR
• DNA Sequencing
• Microarrays
• INAAT Kits

By Application

• Infectious Diseases
• Metabolic Disease
• Genetics
• Other Application

By End-use

• Veterinary Hospitals & Clinics
• Diagnostic Laboratories
• Other End-use

COMPANIES PROFILED

• IDEXX Laboratories, Zoetis, Heska, bioMerieux, Thermo Fisher Scientific, QIAGEN, Neogen, Antech Diagnostics, Bionote, Fujifilm, Virbac, Randox Laboratories, Bio-Rad Laboratories, Laboklin, GeneReach Biotechnology, INDICAL Bioscience, Creative Diagnostics, Eurofins, VCA Animal Hospitals, Mars Veterinary Health

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL VETERINARY MOLECULAR DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Test Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software & Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VETERINARY MOLECULAR DIAGNOSTICS MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Animal Type
• 5.2. Companion Animal Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Production Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VETERINARY MOLECULAR DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. DNA Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Microarrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. INAAT Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VETERINARY MOLECULAR DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Metabolic Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Genetics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other Application Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL VETERINARY MOLECULAR DIAGNOSTICS MARKET: BY END-USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End-use
• 8.2. Veterinary Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Other End-use Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL VETERINARY MOLECULAR DIAGNOSTICS MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product
  • 9.2.2 By Animal Type
  • 9.2.3 By Technology
  • 9.2.4 By Application
  • 9.2.5 By End-use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product
  • 9.3.2 By Animal Type
  • 9.3.3 By Technology
  • 9.3.4 By Application
  • 9.3.5 By End-use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Spain
  • 9.3.11 Russia
  • 9.3.12 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product
  • 9.4.2 By Animal Type
  • 9.4.3 By Technology
  • 9.4.4 By Application
  • 9.4.5 By End-use
  • 9.4.6 China
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 India
  • 9.4.10 Australia
  • 9.4.11 South East Asia
  • 9.4.12 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product
  • 9.5.2 By Animal Type
  • 9.5.3 By Technology
  • 9.5.4 By Application
  • 9.5.5 By End-use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product
  • 9.6.2 By Animal Type
  • 9.6.3 By Technology
  • 9.6.4 By Application
  • 9.6.5 By End-use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL VETERINARY MOLECULAR DIAGNOSTICS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 IDEXX Laboratories
  • 11.2.2 Zoetis
  • 11.2.3 Heska
  • 11.2.4 BioMerieux
  • 11.2.5 Thermo Fisher Scientific
  • 11.2.6 QIAGEN
  • 11.2.7 Neogen
  • 11.2.8 Antech Diagnostics
  • 11.2.9 Bionote
  • 11.2.10 Fujifilm
  • 11.2.11 Virbac
  • 11.2.12 Randox Laboratories
  • 11.2.13 Bio-Rad Laboratories
  • 11.2.14 Laboklin
  • 11.2.15 GeneReach Biotechnology
  • 11.2.16 INDICAL Bioscience
  • 11.2.17 Creative Diagnostics
  • 11.2.18 Eurofins
  • 11.2.19 VCA Animal Hospitals
  • 11.2.20 Mars Veterinary Health